News
TCM product approved for sale in Singapore
Updated: May 7, 2020
By Zhang Yu in Shijiazhuang
chinadaily.com.cn
Print
Share - WeChat
Applications for registration in more countries are underway, including countries in the Middle East, Africa and Latin America, the company said.
Lianhua Qingwen was recommended in four versions of a treatment plan from the National Health Commission for treating COVID-19, the pneumonia associated with the novel coronavirus.
On April 12, the National Medical Products Administration approved adding mild symptoms of COVID-19 as indications for which Lianhua Qingwen is effective.
